In people having a heart attack called STEMI, the amount of a protein called PLIN2 in certain blood cells is higher than in people with stable heart disease, which might be related to why their heart attack happened.
Scientific Claim
Monocyte perilipin-2 (PLIN2) protein expression is significantly higher in patients with ST-elevation myocardial infarction (STEMI) compared to those with chronic coronary syndrome (CCS), with a median fluorescence intensity of 0.94 ± 0.21 versus 0.77 ± 0.13 (p < 0.0001), suggesting a potential association with acute coronary events.
Original Statement
“PLIN2 protein levels resulted higher in STEMI patients compared to CCS patients (0.94 ± 0.21 vs. 0.77 ± 0.13 median fluorescence intensity (MFI); p < 0.0001) (Figure 1).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is observational and shows a difference between groups, but cannot establish causation. The claim uses 'suggesting a potential association' which appropriately reflects the observational nature of the study.